MCU affects breast cancer progression and metastasis through altered ROS generation and HIF1α (hypoxia inducible factor 1 alpha) activity (Tosatto et al. 2016), and silencing MCU may increase caspase‐independent cell death in these models (Curry et al. 2013). Here, HIF1A is linked to breast carcinoma.